Medical interventions for the prevention of platinum-induced hearing loss in children with cancer-Reference-Cited by-同舟云学术

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

Published:2016-09-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van As Jorrit W¹,van den Berg Henk²,van Dalen Elvira C³

Affiliation:

1. Princess Máxima Center for Pediatric Oncology; c/o Cochrane Childhood Cancer; Heidelberglaan 25 Utrecht Netherlands 3584 CS

2. Emma Children's Hospital, Amsterdam UMC, University of Amsterdam; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD

3. Princess Máxima Center for Pediatric Oncology; Heidelberglaan 25 Utrecht Netherlands 3584 CS

Publisher

Wiley

Subject

Pharmacology (medical)

Reference58 articles.

1. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin;Gallegos-Castorena;Pediatric Hematology and Oncology,2007

2. Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group;Katzenstein;Cancer,2009

3. Use of amifostine in the therapy of osteosarcoma in children and adolescents;Petrilli;Journal of Pediatric Hematology/Oncology,2002

4. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival;Petrilli;Journal of Clinical Oncology,2006

5. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors;Doolittle;Clinical Cancer Research,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS);Pediatric Blood & Cancer;2024-07-15

2. Glutathione carbon dots as an intracellular reactive oxygen species scavenger for reducing cisplatin‐induced ototoxicity;VIEW;2023-11-27

3. Hearing and Other Neurologic Problems;Pediatric Clinics of North America;2020-12

4. Current Strategies to Combat Cisplatin-Induced Ototoxicity;Frontiers in Pharmacology;2020-07-03

5. Different infusion durations for preventing platinum-induced hearing loss in children with cancer;Cochrane Database of Systematic Reviews;2020-01-21